Cargando…
A Case of Posterior Reversible Encephalopathy Syndrome Associated with Gilenya(®) (Fingolimod) Treatment for Multiple Sclerosis
We describe posterior reversible encephalopathy syndrome (PRES) in a woman with multiple sclerosis treated with Gilenya(®) (Fingolimod). The first symptoms appeared after 21 months of fingolimod treatment. She experienced headache, altered mental status, cognitive deficits, seizures, and visual dist...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349179/ https://www.ncbi.nlm.nih.gov/pubmed/25788891 http://dx.doi.org/10.3389/fneur.2015.00039 |